PT899267E - Novas trans-3,4,4a,5,6,10b-hexa-hidro-2h-naft(1,2b)-1,4-oxazinas di-substituidas processo para a sua preparacao e as composicoes farmaceuticas que as contem - Google Patents
Novas trans-3,4,4a,5,6,10b-hexa-hidro-2h-naft(1,2b)-1,4-oxazinas di-substituidas processo para a sua preparacao e as composicoes farmaceuticas que as contemInfo
- Publication number
- PT899267E PT899267E PT98402155T PT98402155T PT899267E PT 899267 E PT899267 E PT 899267E PT 98402155 T PT98402155 T PT 98402155T PT 98402155 T PT98402155 T PT 98402155T PT 899267 E PT899267 E PT 899267E
- Authority
- PT
- Portugal
- Prior art keywords
- substituted
- oxazins
- naft
- hexa
- hydro
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 239000002253 acid Substances 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000000304 alkynyl group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 1
- 125000001475 halogen functional group Chemical group 0.000 abstract 1
- 125000004356 hydroxy functional group Chemical group O* 0.000 abstract 1
- 230000003287 optical effect Effects 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000004076 pyridyl group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000001544 thienyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Anesthesiology (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Medicinal Preparation (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9710852A FR2767825A1 (fr) | 1997-09-01 | 1997-09-01 | Nouvelles trans-3,4,4a,5,6,10b-hexahydro-2h-napht°1,2-b!-1, 4-oxazines disubstituees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT899267E true PT899267E (pt) | 2003-04-30 |
Family
ID=9510643
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT98402155T PT899267E (pt) | 1997-09-01 | 1998-09-01 | Novas trans-3,4,4a,5,6,10b-hexa-hidro-2h-naft(1,2b)-1,4-oxazinas di-substituidas processo para a sua preparacao e as composicoes farmaceuticas que as contem |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US6025356A (enExample) |
| EP (1) | EP0899267B1 (enExample) |
| JP (1) | JP4417451B2 (enExample) |
| CN (1) | CN1088064C (enExample) |
| AT (1) | ATE229513T1 (enExample) |
| AU (1) | AU740928C (enExample) |
| BR (1) | BR9803933A (enExample) |
| CA (1) | CA2246482C (enExample) |
| DE (1) | DE69810034T2 (enExample) |
| DK (1) | DK0899267T3 (enExample) |
| ES (1) | ES2189108T3 (enExample) |
| FR (1) | FR2767825A1 (enExample) |
| HU (1) | HU226059B1 (enExample) |
| NO (1) | NO311218B1 (enExample) |
| NZ (1) | NZ331637A (enExample) |
| PL (1) | PL194533B1 (enExample) |
| PT (1) | PT899267E (enExample) |
| ZA (1) | ZA987963B (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0130219D0 (en) * | 2001-12-18 | 2002-02-06 | Pfizer Ltd | Compounds for the treatment of sexual dysfunction |
| CA2496452A1 (en) * | 2002-08-30 | 2004-03-11 | Biostratum, Inc. | Inhibitors of post-amadori advanced glycation end products |
| EP1620083A2 (en) * | 2003-04-18 | 2006-02-01 | Pharmacia & Upjohn Company LLC | Combination therapies |
| FR2906249B1 (fr) * | 2006-09-26 | 2008-12-19 | Servier Lab | Composes tetracycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| EP2098511A1 (en) | 2008-03-07 | 2009-09-09 | Solvias AG | Process for preparing compounds containing a hydronaphtalene structure with an unsymmetrically substituted benzene ring |
| WO2009156458A1 (en) * | 2008-06-27 | 2009-12-30 | H. Lundbeck A/S | Novel phenolic and catecholic amines and prodrugs thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4420480A (en) * | 1981-11-20 | 1983-12-13 | Merck & Co., Inc. | Hexahydronaphth[1,2-b]-1,4-oxazines |
| CA1204745A (en) * | 1981-11-20 | 1986-05-20 | Merck Co. | Hexahydronaphth (1,2-b) -1,4 -oxazines |
| US4540691A (en) * | 1984-04-13 | 1985-09-10 | Nelson Research & Development Co. | Dopamine agonists and use thereof |
| US5486611A (en) * | 1989-07-13 | 1996-01-23 | The Upjohn Company | Carboxamido-(1,2N)-carbocyclic-2-aminotetralin derivatives |
| WO1991019719A1 (en) * | 1990-06-15 | 1991-12-26 | Whitby Research, Inc. | Substituted naphthoxazines useful as dopaminergics |
-
1997
- 1997-09-01 FR FR9710852A patent/FR2767825A1/fr active Pending
-
1998
- 1998-08-31 NO NO19984007A patent/NO311218B1/no not_active IP Right Cessation
- 1998-08-31 BR BR9803933-4A patent/BR9803933A/pt not_active Application Discontinuation
- 1998-08-31 NZ NZ331637A patent/NZ331637A/xx not_active IP Right Cessation
- 1998-08-31 CA CA002246482A patent/CA2246482C/fr not_active Expired - Fee Related
- 1998-08-31 PL PL328285A patent/PL194533B1/pl not_active IP Right Cessation
- 1998-08-31 CN CN98119987A patent/CN1088064C/zh not_active Expired - Fee Related
- 1998-08-31 HU HU9801951A patent/HU226059B1/hu not_active IP Right Cessation
- 1998-08-31 US US09/144,025 patent/US6025356A/en not_active Expired - Lifetime
- 1998-09-01 AT AT98402155T patent/ATE229513T1/de active
- 1998-09-01 DK DK98402155T patent/DK0899267T3/da active
- 1998-09-01 PT PT98402155T patent/PT899267E/pt unknown
- 1998-09-01 DE DE69810034T patent/DE69810034T2/de not_active Expired - Lifetime
- 1998-09-01 JP JP24691098A patent/JP4417451B2/ja not_active Expired - Fee Related
- 1998-09-01 ES ES98402155T patent/ES2189108T3/es not_active Expired - Lifetime
- 1998-09-01 AU AU83024/98A patent/AU740928C/en not_active Ceased
- 1998-09-01 ZA ZA987963A patent/ZA987963B/xx unknown
- 1998-09-01 EP EP98402155A patent/EP0899267B1/fr not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| HUP9801951A2 (hu) | 2000-02-28 |
| EP0899267A1 (fr) | 1999-03-03 |
| CN1222516A (zh) | 1999-07-14 |
| US6025356A (en) | 2000-02-15 |
| AU740928C (en) | 2002-05-16 |
| NO984007L (no) | 1999-03-02 |
| JPH11130759A (ja) | 1999-05-18 |
| HUP9801951A3 (en) | 2000-04-28 |
| NO984007D0 (no) | 1998-08-31 |
| NO311218B1 (no) | 2001-10-29 |
| DE69810034T2 (de) | 2003-08-14 |
| CA2246482C (fr) | 2002-11-26 |
| HU226059B1 (en) | 2008-04-28 |
| CN1088064C (zh) | 2002-07-24 |
| CA2246482A1 (fr) | 1999-03-01 |
| DK0899267T3 (da) | 2003-03-10 |
| AU740928B2 (en) | 2001-11-15 |
| PL194533B1 (pl) | 2007-06-29 |
| HK1020340A1 (en) | 2000-04-14 |
| AU8302498A (en) | 1999-03-11 |
| DE69810034D1 (de) | 2003-01-23 |
| BR9803933A (pt) | 2001-04-24 |
| ATE229513T1 (de) | 2002-12-15 |
| PL328285A1 (en) | 1999-03-15 |
| EP0899267B1 (fr) | 2002-12-11 |
| ES2189108T3 (es) | 2003-07-01 |
| HU9801951D0 (en) | 1998-11-30 |
| JP4417451B2 (ja) | 2010-02-17 |
| NZ331637A (en) | 1999-07-29 |
| FR2767825A1 (fr) | 1999-02-26 |
| ZA987963B (en) | 1999-03-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HU9600278D0 (en) | Remedy for nervous diseases | |
| BR9703447A (pt) | Novos compostos 3-(piperid-4-il)-1,2-benzisoxazol e 3-(piperazin-4-il) 1,2-benzisoxazol processos para a preparação dos mesmos e composições farmacêuticas contendo os mesmo | |
| PT97710A (pt) | Processo para a preparacao de novos derivados da amino-piperidina,da amino-pirrolidina e de amino-per-hidroazepina | |
| HUP0000610A2 (hu) | Fájdalomcsillapító hatású piperidinszármazékok, eljárás előállításukra és a vegyületeket tartalmazó gyógyszerkészítmények | |
| AR024390A1 (es) | Nuevos compuestos | |
| PT81855B (pt) | Processo de preparacao de arilciclobutilalquilaminas e de composicoes farmaceuticas que as contem | |
| PT899267E (pt) | Novas trans-3,4,4a,5,6,10b-hexa-hidro-2h-naft(1,2b)-1,4-oxazinas di-substituidas processo para a sua preparacao e as composicoes farmaceuticas que as contem | |
| BR8901097A (pt) | Processo para a preparacao de uma composicao biocida | |
| ES2160197T3 (es) | Empleo de una sal de sodio o de lisinio de derivados de amida del acido crotonico para la preparacion de un medicamento para el tratamiento de enfermedades cancerigenas. | |
| KR900018091A (ko) | 진경제 | |
| DK0573473T3 (da) | 4-((2-benzothiazolyl)methylamino)-alfa-((3,4-difluorphenoxy)methyl)-1-piperidinethanol | |
| ZA964842B (en) | Indole indazole and benzisoxazole compounds their process of preparation and the pharmaceutical compositions which contain them | |
| NO972943L (no) | 4-amino-2-ureido-pyrimidin-5-karboksylsyreamider, fremgangsmåter for deres fremstilling, legemidler inneholdende dem og deres anvendelse | |
| HU9503597D0 (en) | Use of 1,2-alkylene-1,4-dihydro-pyridine derivatives as medicine | |
| NO964672L (no) | Nye tetracykliske 1,4-oksazinforbindelser, fremgangsmåter ved deres fremstilling og farmasöytiske sammensetninger innholdende dem | |
| PT816359E (pt) | 4-amino-2-ureido-pirimidina-5-carboxamidas, processo para a sua preparacao, medicamentos que contem estes compostos e sua utilizacao | |
| BR9801386A (pt) | Novos compostos de 6,7,8,9 - tetraidro-ciclopenta(a) naftaleno e de 2,3-didro-coclopenta(e) indeno processo para preparação dos mesmos e composições farmacêuticas contendo os mesmos | |
| PT92668A (pt) | Processo para a preparacao de derivados de azabiciclo-heptano | |
| PT87954A (pt) | Processo para a preparacao de composicoes farmaceuticas contendo derivados de dioxopiperidina, com efeito antipsicotico | |
| ATE200780T1 (de) | Aminoalkyl benzothiazolinone, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen die sie enthalten | |
| PT768307E (pt) | Aminas heterociclicas terrciarias processo para a sua preparacao e as composicoes farmaceuticas que as contem |